Skip to main content
logo
Barinthus Biotherapeutics plc (BRNS)
NASDAQ: BRNS · Real-Time Price · USD
1.070
+0.020 (1.90%)
Sep 17, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Immunotherapies and Vaccines
14.97M
Log In
Log In
Log In
Log In
Upgrade
Immunotherapies and Vaccines Growth
1766.46%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
United Kingdom
14.97M
Log In
Log In
Log In
Log In
Upgrade
United Kingdom and United States
-
Log In
Log In
Log In
Log In
Upgrade
United Kingdom and United States Growth
-
Log In
Log In
Log In
Log In
Upgrade